Forty adult human community volunteers (21 females) were tested using a double-blind, placebo-controlled design. All participants had normal or corrected-to-normal vision and reported no prior history of neuropsychiatric illness, or previous conditions or medication that contraindicate the administration of 40mg propranolol (cardiovascular disease, lung/ kidney/liver disease, substance use, pregnancy).

The study was approved by the UCL Ethics Committee (#1338/007).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.